• Products
    • Biosensor Assays
      • TempoATP™ for ATP Metabolism
      • TempoCAL™ for Calcium
      • TempoMito™ for Mitochondria
      • TempoO2™ for Oxygen Metabolism
      • TempoVOL™ for Cationic Voltage
    • Induced Pluripotent Stem Cells (IPSC)
      • iAstro™ Astrocytes
      • iBMEC™ Brain Microvascular Endothelial Cells
      • iCardio™ Cardiomyocytes
      • iCort™ Cortical Neurons
      • iDopaNer™ Dopaminergic Neurons
      • iHep3D Hepatocytes
      • iHepStellate Hepatic Stellate
      • iHepStellate™-iKupffer™-iLSEC™-iHep3D™ 3D organoid
      • iKer™ Keratinocytes
      • iKidneyPod™ Kidney Proximal Tubules and Podocyte 3D Spheroids
      • iKupffer Kupffer Cells
      • iLSEC Liver Sinusoidal Endothelials
      • iMel™ Melanocytes
      • iMG™ Microglia
      • iMono™ CD14+ Monocytes
      • iMotorNer™ Motor Neurons
      • iMSC™ Mesenchymal
      • iNStem™ Neural Progenitor
      • iOligo™ Oligodendrocyte Progenitor
      • iOsteo™ Osteoblasts
      • iPeri™ Pericytes
      • iPhago™ Phagocytes
      • iRPE™ Retinal Pigment Epithelials
      • iSchwann™ Schwann
      • iSenso™ Sensory Neurons
    • TempoStemBank™
    • Cell Culture Solutions
  • Applications
  • Services & Support
    • Services
      • Bespoke Assays
      • Assay Partnerships
    • Support
  • Tempo Bioscience
    • Careers
    • Company Overview
    • News
    • Contact
  • Resources
    • Cell Culture Technique
    • Citation Alert
    • Disease Models
    • Industry News
    • Trends
NASH – The Urgent Need for Better Disease Models and New Therapies

NASH – The Urgent Need for Better Disease Models and New Therapies

by Karen O'Hanlon Cohrt | Apr 4, 2023 | Disease Models

Welcome to our new mini-series about liver organoids. In Part 1, we focus on non-alcoholic steatohepatitis (NASH), a severe and prevalent form of non-alcoholic fatty liver disease for which no drugs have been approved. We look at the current treatment landscape for...
Better Blood Brain Barrier Models Are Urgently Needed for Modern Therapeutic Advances

Better Blood Brain Barrier Models Are Urgently Needed for Modern Therapeutic Advances

by Karen O'Hanlon Cohrt | Feb 19, 2023 | Trends

Welcome to Part 4 of our series about the blood brain barrier (BBB)! Here, we highlight the rising global burden of neurological disorders, and recap on the challenges surrounding drug safety and toxicity in relation to the BBB. As industry speeds ahead with novel...
Sources of cells for modeling the human BBB — 4 considerations

Sources of cells for modeling the human BBB — 4 considerations

by Karen O'Hanlon Cohrt | Jan 26, 2023 | Trends

Welcome to Part 3 of our blog series covering the blood brain barrier (BBB). In Part 1, we looked briefly at how the BBB was discovered and presented what we currently know about its composition and functions. Part 2 focused on the need for reliable BBB models in drug...
In Vitro Blood Brain Barrier Models for Drug Development

In Vitro Blood Brain Barrier Models for Drug Development

by Karen O'Hanlon Cohrt | Dec 18, 2022 | Trends

Welcome back to our blog series about the blood brain barrier (BBB). In Part 1, we provided a brief history on the discovery of the BBB, and introduced what we currently know about its composition and biological functions. In Part 2, we explain why reliable BBB models...
What is the Blood Brain Barrier? Part 1 of a Series

What is the Blood Brain Barrier? Part 1 of a Series

by Karen O'Hanlon Cohrt | Nov 18, 2022 | Trends

Welcome to our new blog series about the blood brain barrier (BBB)! In Part 1, we will give a brief history on the discovery of the BBB, as well as introduce what we know about its composition and biological functions. The blood brain barrier or BBB is a highly...
« Older Entries

About Tempo BioScience

Fascinated by self-assembly of cells in spheroids or organoids? Excited to develop and characterize functionally relevant human iPSC disease models? Tempo Bioscience is a cash-positive product-focused trendsetter in the areas of human iPSCs and novel proprietary biosensors. We are growing and are looking for key hires to expand.  Join us and be a part of the team that will grow the company from the ground up and build a business that lasts.

Our Mission is to develop patient-relevant iPSC-based models for 10,000+ human diseases to advance science and medicine. 

Our Values are respect, communication, and teamwork.

Resources

Tempo-iMG™: Architectural Strategies

Tempo-iMG™: Architectural Strategies

Tempo-iMG™ was cited in cell.com in a study that investigated HIV-1 integration in the unexplored microglia reservoir that gives rise to continued HIV replication in infected cells. Scientists...

read more
NASH – The Urgent Need for Better Disease Models and New Therapies

NASH – The Urgent Need for Better Disease Models and New Therapies

Welcome to our new mini-series about liver organoids. In Part 1, we focus on non-alcoholic steatohepatitis (NASH), a severe and prevalent form of non-alcoholic fatty liver disease for which no...

read more
Better Blood Brain Barrier Models Are Urgently Needed for Modern Therapeutic Advances

Better Blood Brain Barrier Models Are Urgently Needed for Modern Therapeutic Advances

Welcome to Part 4 of our series about the blood brain barrier (BBB)! Here, we highlight the rising global burden of neurological disorders, and recap on the challenges surrounding drug safety...

read more
  • Products
    • Biosensor Assays
      • TempoATP™ for ATP Metabolism
      • TempoCAL™ for Calcium
      • TempoMito™ for Mitochondria
      • TempoO2™ for Oxygen Metabolism
      • TempoVOL™ for Cationic Voltage
    • Induced Pluripotent Stem Cells (IPSC)
      • iAstro™ Astrocytes
      • iBMEC™ Brain Microvascular Endothelial Cells
      • iCardio™ Cardiomyocytes
      • iCort™ Cortical Neurons
      • iDopaNer™ Dopaminergic Neurons
      • iHep3D Hepatocytes
      • iHepStellate Hepatic Stellate
      • iHepStellate™-iKupffer™-iLSEC™-iHep3D™ 3D organoid
      • iKer™ Keratinocytes
      • iKidneyPod™ Kidney Proximal Tubules and Podocyte 3D Spheroids
      • iKupffer Kupffer Cells
      • iLSEC Liver Sinusoidal Endothelials
      • iMel™ Melanocytes
      • iMG™ Microglia
      • iMono™ CD14+ Monocytes
      • iMotorNer™ Motor Neurons
      • iMSC™ Mesenchymal
      • iNStem™ Neural Progenitor
      • iOligo™ Oligodendrocyte Progenitor
      • iOsteo™ Osteoblasts
      • iPeri™ Pericytes
      • iPhago™ Phagocytes
      • iRPE™ Retinal Pigment Epithelials
      • iSchwann™ Schwann
      • iSenso™ Sensory Neurons
    • TempoStemBank™
    • Cell Culture Solutions
  • Applications
  • Services & Support
    • Services
      • Bespoke Assays
      • Assay Partnerships
    • Support
  • Tempo Bioscience
    • Careers
    • Company Overview
    • News
    • Contact
  • Resources
    • Cell Culture Technique
    • Citation Alert
    • Disease Models
    • Industry News
    • Trends

©2023 TempoBioscience. All rights reserved. Privacy Policy | Terms of Use.

X